WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H526505
CAS#: 53746-46-6
Description: Trimazosin hydrochloride is used in the treatment of hypertensive patients failing to respond to thiazides.
Hodoodo Cat#: H526505
Name: Trimazosin hydrochloride
CAS#: 53746-46-6
Chemical Formula: C20H32ClN5O7
Exact Mass: 489.20
Molecular Weight: 489.954
Elemental Analysis: C, 49.03; H, 6.58; Cl, 7.24; N, 14.29; O, 22.86
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 35795-17-6 (HCl) 53746-46-6 (HCl hydrate) 35795-16-5 (free base)
Synonym: CP-19106-1; CP19106-1; CP 19106-1; Trimazosin hydrochloride; Trimazosin HCl.
IUPAC/Chemical Name: 2-hydroxy-2-methylpropyl 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate hydrochloride hydrate
InChi Key: WXMXALSEIGHTOR-UHFFFAOYSA-N
InChi Code: InChI=1S/C20H29N5O6.ClH.H2O/c1-20(2,27)11-31-19(26)25-8-6-24(7-9-25)18-22-14-12(17(21)23-18)10-13(28-3)15(29-4)16(14)30-5;;/h10,27H,6-9,11H2,1-5H3,(H2,21,22,23);1H;1H2
SMILES Code: O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=C(OC)C3=N2)CC1)OCC(C)(O)C.[H]Cl.[H]O[H]
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 489.95 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Vincent J, Hamilton CA, Reid JL. The cardiovascular effects of trimazosin and prazosin in the rabbit. Clin Exp Pharmacol Physiol. 1986 Aug;13(8):593-608. PubMed PMID: 2878751.
2: Moyer RR. A double-blind study of trimazosin and methyldopa in hypertensive patients receiving polythiazide. Am Heart J. 1983 Nov;106(5 Pt 2):1250-3. PubMed PMID: 6356853.
3: Constantine JW, Lebel W, Weeks R. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade. J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):142-50. PubMed PMID: 6199597.
4: Singleton W, Taylor CR. Effect of trimazosin on serum lipid profiles in hypertensive patients. Am Heart J. 1983 Nov;106(5 Pt 2):1265-8. PubMed PMID: 6356856.
5: Helgeland A. Double-blind comparison of trimazosin and propranolol in essential hypertension. Am Heart J. 1983 Nov;106(5 Pt 2):1253-8. PubMed PMID: 6356854.
6: Vincent J, Elliott HL, Meredith PA, Reid JL. Trimazosin: relationships between hypotensive effect, vascular responsiveness, and drug and metabolite concentrations. J Cardiovasc Pharmacol. 1985 Sep-Oct;7(5):913-8. PubMed PMID: 2413300.
7: Vincent J, Elliott HL, Meredith PA, Hughes DM, Reid JL. The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha 1-adrenoceptor responsiveness of trimazosin in man. Eur J Clin Pharmacol. 1985;29(3):301-6. PubMed PMID: 3000797.
8: Reid JL, Meredith PA, Elliott HL. Pharmacokinetics and pharmacodynamics of trimazosin in man. Am Heart J. 1983 Nov;106(5 Pt 2):1222-8. PubMed PMID: 6637788.
9: Oberman A, Pool PE. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides. Am Heart J. 1983 Nov;106(5 Pt 2):1258-64. PubMed PMID: 6356855.
10: Weber MA, Brewer DD, Drayer JI, Aronow WS, Lipson JL, Ricci BA. A vasodilator that avoids renin stimulation and fluid retention: antihypertensive treatment with trimazosin. Clin Pharmacol Ther. 1982 May;31(5):572-8. PubMed PMID: 7042174.
11: Constantine JW, Lebel W, Weeks R. Effects of trimazosin and prazosin on blood pressure and on pressor responses to phenylephrine in rats. Am Heart J. 1983 Nov;106(5 Pt 2):1216-21. PubMed PMID: 6637787.
12: Chrysant SG. Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients. Am Heart J. 1983 Nov;106(5 Pt 2):1243-50. PubMed PMID: 6356852.
13: Webb DJ, Hutcheson MJ, Robertson MP, Murray GD, Lorimer AR, Robertson JI. A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertension. Scott Med J. 1985 Apr;30(2):106-10. PubMed PMID: 3892676.
14: Byyny RL, Nies AS, LoVerde ME, Mitchell WD. Effect of a sustained-release formulation of trimazosin in mild to moderate hypertension. J Clin Pharmacol. 1987 Feb;27(2):101-5. PubMed PMID: 3680560.
15: Hughes MA, Meredith PA, Elliott HL. The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection. J Pharmacol Methods. 1984 Aug;12(1):29-34. PubMed PMID: 6536811.
16: Elliott HL, Vincent J, Hughes DM, Meredith PA, Reid JL. Trimazosin in normotensive subjects. Clin Pharmacol Ther. 1984 Feb;35(2):156-60. PubMed PMID: 6141018.
17: Nelson GI, Hussain M, Forsyth D, Wilson J, Silke B, Taylor SH. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension. J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):176-81. PubMed PMID: 6199601.
18: Taylor CR, Leader JP, Singleton W, Munster EW, Falkner FC, O'Neil JA. Profile of trimazosin: an effective and safe antihypertensive agent. Am Heart J. 1983 Nov;106(5 Pt 2):1269-81. PubMed PMID: 6227228.
19: Singleton W, Saxton CA, Hernandez J, Prichard BN. Postjunctional selectivity of alpha-blockade with prazosin, trimazosin, and UK-33,274 in man. J Cardiovasc Pharmacol. 1982;4 Suppl 1:S145-51. PubMed PMID: 6175830.
20: Constantine JW, Hess HJ. The cardiovascular effects of trimazosin. Eur J Pharmacol. 1981 Sep 11;74(2-3):227-38. PubMed PMID: 6120084.